Starting
Initialising…
0%
PTEN
Final classification
Likely Pathogenic
PTEN c.304A>T · p.Lys102Ter
PTEN

The PTEN NM_000314.8:c.304A>T (p.Lys102Ter, p.K102*) variant has not been observed in somatic cancers in COSMIC and has been reported in ClinVar as pathogenic by one clinical laboratory.

Gene
PTEN
Transcript
NM_000314.8
HGVS · transcript:coding
NM_000314.8:c.304A>T
Consequence
N/A
GRCh38
chr10:87933063 A>T
GRCh37
chr10:89692820 A>T
Basis Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework: matched Rule20 (1 Pathogenic.Very Strong + 1 Pathogenic.Supporting) with applied criteria: PVS1 very strong, PM2 supporting; maps to Likely Pathogenic.
Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework: matched Rule20 (1 Pathogenic.Very Strong + 1 Pathogenic.Supporting) with applied criteria: PVS1 very strong, PM2 supporting; maps to Likely Pathogenic.
Classification rationale
PVS1PM2 Likely Pathogenic
PTEN c.304A>T

The PTEN NM_000314.8:c.304A>T (p.Lys102Ter, p.K102*) variant has not been observed in somatic cancers in COSMIC and has been reported in ClinVar as pathogenic by one clinical laboratory.1 This variant is absent from gnomAD v2.1 and gnomAD v4.1, which is below the PTEN PM2_Supporting threshold of 0.001% and supports rarity in population databases.2 This is an early truncating PTEN variant, and under the PTEN-specific PVS1 decision tree a stop codon at codon 102 is upstream of the p.D375 (c.1121) threshold used for full-strength PVS1.3 SpliceAI predicts no significant splice effect with a maximum delta score of 0.04, and a BayesDel score of 0.652534 is available; however, the PTEN VCEP PP3/BP4 computational rules are specified for missense or defined splicing variants and were not applied to this nonsense variant.4

PVS1 + PM2 Likely Pathogenic
3 cspec ↗pvs1_gene_contextpvs1_variant_assessmentvcep_pvs1_decisiontree_pten
Gene diagram · NM_000314.8 · variants mapped to exon structure
PTEN NM_000314.8
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports pathogenic
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      Absent from gnomAD v4.1.
      v2.1
      Absent from gnomAD v2.1.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Pathogenic (1 clinical laboratory).
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.04). BayesDel score = 0.652534.
      Functional / OncoKB screenshot
      Functional Likely Oncogenic
      OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots